SynthesisCancer research and treatment2021

Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis.

Toshikazu Moriwaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.